September 2022
Training opportunities available to learn more about pharmacogenomics
Action item
Consider taking advantage of educational opportunities to learn about pharmacogenomics, the study of how an individual’s genetic makeup affects how he or she responds to medications.
As you’ve read in our provider publications previously, Blue Care Network is launching a new program, Blue Cross Personalized Medicine℠, to help physicians tailor the medication regimen of patients to their specific needs through pharmacogenomics, or PGx.
BCN is currently testing the Blue Cross Personalized Medicine program with a limited number of eligible members. The full launch of a PGx program for all eligible BCN members will begin in January 2023.
OneOme, an independent precision medicine company co-founded by the Mayo Clinic, has contracted with Blue Care Network to introduce this precision medicine program for eligible BCN members. The company is pleased to offer some educational opportunities for physicians, pharmacists and other clinicians who would like to learn more about pharmacogenomics.
Training opportunities
We encourage you to participate in the following educational opportunities if you’d like to learn more about pharmacogenomics. BCN Chief Medical Officer and Vice President of Strategy and Affordability Scott Betzelos, M.D., and OneOme Medical Director Julie England, M.D., will be panelists at the Orlando conference on Sept. 28. There is a cost to participate in these training opportunities.
If you’re unable to attend, visit oneome.com/bcbsm-webinar** to view previous educational webinars or for contact information to reach out to a member of OneOme’s clinical team.
For more information
You can read more about this program in these publications:
**Blue Care Network doesn’t own or control this website. |